NasdaqCM - Delayed Quote • USD
NeuroMetrix, Inc. (NURO)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 7:35 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | 1.5 | -3.7 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 22.3M | 22.3M | 22.3M | 26.72M |
| Low Estimate | 22.3M | 22.3M | 22.3M | 26.72M |
| High Estimate | 22.3M | 22.3M | 22.3M | 26.72M |
| Year Ago Sales | -- | -- | -- | 22.3M |
| Sales Growth (year/est) | -- | -- | -- | 19.80% |
Earnings History
| CURRENCY IN USD | 3/31/2019 | 6/30/2019 | 9/30/2019 | 12/31/2019 |
|---|---|---|---|---|
| EPS Est. | -1.5 | -1.9 | -1.5 | -1.8 |
| EPS Actual | 1.5 | -3.7 | -1.4 | -3 |
| Difference | 3 | -1.8 | 0.1 | -1.2 |
| Surprise % | 200.00% | -94.70% | 6.70% | -66.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0.4 | 2.3 |
| 30 Days Ago | 0 | 0 | 0.4 | 2.3 |
| 60 Days Ago | 0 | 0 | 0.4 | 2.3 |
| 90 Days Ago | 0 | 0 | 0.4 | 2.3 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NURO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.60% |
| Next Qtr. | -- | -- | -- | 10.50% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Related Tickers
BBLG Bone Biologics Corporation
1.6100
-10.56%
BJDX Bluejay Diagnostics, Inc.
0.5500
-3.51%
TIVC Tivic Health Systems, Inc.
1.1100
-4.31%
HYPR Hyperfine, Inc.
0.8300
+2.47%
TNON Tenon Medical, Inc.
0.7331
-4.32%
USAQ QHSLab, Inc.
0.0830
+36.07%
PAX.ST Paxman AB (publ)
34.90
-0.29%
BVS Bioventus Inc.
4.4800
-1.54%
TBIO Telesis Bio, Inc.
0.3090
-6.42%
HSCS Heart Test Laboratories, Inc.
0.1001
-7.74%